+ All Categories
Home > Documents > Innovation Across Borders - Session 5 yousef haj ahmad

Innovation Across Borders - Session 5 yousef haj ahmad

Date post: 12-Apr-2017
Category:
Upload: mars-discovery-district
View: 1,011 times
Download: 0 times
Share this document with a friend
10
© 2008 Norgen Biotek Corp. ing the picks and shovels for the 21st century's genetics gol ing the picks and shovels for the 21st century's genetics gol
Transcript
Page 1: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

““Providing the picks and shovels for the 21st century's genetics gold rush”Providing the picks and shovels for the 21st century's genetics gold rush”

Page 2: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

Norgen Biotek Corp.Norgen Biotek Corp. A fully integrated biotechnology company State-of-the-art facilities Over 300 products Patented purification technology Manufacture products in our facility ISO 9001:2008, ISO 13845:2003, Certified, Medical Device Establishment License (Canada) Clean room, ISO class 5 and 7

Page 3: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

CapabilitiesCapabilities

1- R&D Intensive (IP); very experienced scientific staff2- Products based on patented technology3- Automated manufacturing4- Rich product pipe-line5- Quality systems & certifications6- Concept-to-product

Page 4: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

The Technology: The Technology: Unique With Strong IP PositionUnique With Strong IP Position

Title Jurisdiction Patent No. or App. No.

Nucleic Acid Purification and Process USA 6,177,278 B1 (issued Jan 23/01)

Nucleic Acid Purification and Process USA 6,291,248 (issued Sep 18/01)

Process for Nucleic Acid Purification Using Silicon Carbide Australia 770721 (issued Jun 10/04)

Process for Nucleic Acid Purification Using Silicon Carbide UK 2,363,795B (issued Oct 15/03)

Nucleic Acid Purification and Process Australia 2002302045 (issued May 20/04)

Process for Nucleic Acid Purification Using Silicon Carbide WIPO PCT/CA00/00424

Process for Nucleic Acid Purification Using Silicon Carbide Germany 10084502.9 (filed Apr 20/00)

Process for Nucleic Acid Purification Using Silicon Carbide Europe 00920300.1 (filed Apr 20/00)

Process for Nucleic Acid Purification Using Silicon Carbide Japan 2000-614,378 (filed Apr 20/00)

Process for Nucleic Acid Purification Using Silicon Carbide Hong Kong 02105432.3 (filed Jul 23/02)

Nucleic Acid Purification and Process Canada 2,270,106 (filed Apr 23/99)

Method of Protein Purification USA 10/294,283 (filed Nov 13/02)

Method of Protein Purification Canada 2,467,048 (filed Oct 30/05)

Method of Protein Purification Australia 2002335952 (filed Oct 30/02)

Method of Protein Purification Japan 2003-545679 (filed Jul 02/04)

Method of Protein Purification Europe 02769802.6 (filed Oct 30/02)

Industrial Silicon Filtration Method Canada (filed Aug 31/05)

Treatment of Silicon Carbide to Enhance Binding Ability USA 10/379,383 (filed Mar 05/03)

Dozen of patents issued Dozen of patents issued and others pendingand others pending

Page 5: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

DiagnosticDiagnostic AnalyticalAnalytical IndustrialIndustrial

fgfg µgµg kgkg

Robust Technology at Various ScalesRobust Technology at Various Scales

Spin-outIndustrial Scale

Current FocusDiagnostics

Past/present FocusKits

Page 6: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

The Products: The Products: Complementary PortfolioComplementary Portfolio

1. RNA Purification Kits2. DNA Isolation/Clean Up Kits 3. Protein Purification/Concentration/Clean Up Kits 4. Blood/Plasma/Serum Sample Preparation Kits5. Urine Sample Preparation Kits6. Preservation & Transport Reagents (Urine, Saliva, Blood, etc….)7. Molecular Diagnostic Kits (Research Use Only)8. PCR Reagents9. Molecular Weight Ladders: DNA, RNA, Protein10. Buffers & Chemicals11. Plastics and Filtration Devices

Page 7: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

CommercializationCommercializationFour complementary strategies:Four complementary strategies:

Direct Sales via the Web Global & Regional Distributors OEM Partners Bundle Sample Preparation with Dx Kits

Page 8: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

Direct Sales: Direct Sales: Who are Our Customers?Who are Our Customers?

Companies Universities Institutes Merck Harvard Medical School John’s Hopkin’s UniversityGlaxoSmithKline Yale University The Mayo ClinicPfizer Stanford University MIT GE HealthCare NIH MD AndersonAventis McGill University Princess Margaret HospitalNovartis Charles River Mount Sinai HospitalWyeth Iowa State University Penn State UniversityJohnson & Johnson Queen's University North Carolina State UniversityQuest Diagnostics McMaster University St. Michael's HospitalQiagen University of Guelph Virginia TechInvitrogen Corp University of Colorado Texas A & MNew England Biolabs Covance Roswell Park Cancer InstituteMillipore Corp Michigan State University Mount Sinai HospitalThermo Fisher Scientific Cornell University Illinois Institute of TechnologyEMD Serono Quintiles Institute of Systems Biology

And many more......

Page 9: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

OEMCanada Spain New Zealand Kuwait Thermo USA Portugal Japan Turkey ExiqonMexico Finland China Egypt AmrescoBrazil Switzerland Malaysia Jordan OrigeneChile Bulgaria Thailand Israel BiosynthesisUK Romania Vietnam South Africa LucigenGermany Slovakia India ServaThe Netherlands

Czech Republic

PakistanBelgium Hungary South KoreaLuxembourg Austria TaiwanFrance Italy

International Distributors

International Distributors International Distributors And OEM PartnersAnd OEM Partners

Page 10: Innovation Across Borders - Session 5 yousef haj ahmad

© 2008 Norgen Biotek Corp.

Intellectual Property StrategyIntellectual Property Strategy

1. Build Manufacturing Capacity 2. Out-licensing:

1. Exclusive, 2. Non-Exclusive, 3. Co-Exclusive

3. Exploit Robustness of the Technology

Will discuss these and other issues


Recommended